Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Wirth

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Headache|August 31, 2020
Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic MigraineCarrie R Houts, R J Wirth, James S McGinley, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 20, 2020
Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 studyCarrie R Houts, James S McGinley, R J Wirth, et al.
Headache|February 16, 2023
Longitudinal assessment of comorbidities and co-occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)James S McGinley, Andrea Savord, Dawn C Buse, et al.
Schizophrenia Research|January 30, 2009
A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinationsDavid L Penn, Piper S Meyer, Elizabeth Evans, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 8, 2016
Development of the Contact Lens User Experience: CLUE ScalesR J Wirth, Michael C Edwards, Michael Henderson, et al.
Headache|September 8, 2017
Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS StudyRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.
Schizophrenia Research|October 23, 1998
Mini-Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophreniaR Ganguli, J S Brar, H Vemulapalli, et al.
Headache|February 19, 2021
Between and within-woman differences in the association between menstruation and migraine daysJames S McGinley, R J Wirth, Jelena M Pavlovic, et al.
Headache|December 8, 2019
Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative ReviewCarrie R Houts, R J Wirth, James S McGinley, et al.
Headache|May 8, 2019
Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized TrialJames S McGinley, Dawn C Buse, Kenneth J Shulman, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Headache|August 31, 2020
Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic MigraineCarrie R Houts, R J Wirth, James S McGinley, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 20, 2020
Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 studyCarrie R Houts, James S McGinley, R J Wirth, et al.
Headache|February 16, 2023
Longitudinal assessment of comorbidities and co-occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)James S McGinley, Andrea Savord, Dawn C Buse, et al.
Schizophrenia Research|January 30, 2009
A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinationsDavid L Penn, Piper S Meyer, Elizabeth Evans, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|July 8, 2016
Development of the Contact Lens User Experience: CLUE ScalesR J Wirth, Michael C Edwards, Michael Henderson, et al.
Headache|September 8, 2017
Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS StudyRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.
Schizophrenia Research|October 23, 1998
Mini-Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophreniaR Ganguli, J S Brar, H Vemulapalli, et al.
Headache|February 19, 2021
Between and within-woman differences in the association between menstruation and migraine daysJames S McGinley, R J Wirth, Jelena M Pavlovic, et al.
Headache|December 8, 2019
Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative ReviewCarrie R Houts, R J Wirth, James S McGinley, et al.
Headache|May 8, 2019
Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized TrialJames S McGinley, Dawn C Buse, Kenneth J Shulman, et al.
Pageof 5